Next-generation everolimus-eluting coronary stent gains US approval
Cardiology Today
The FDA has approved a next-generation everolimus-eluting coronary stent for the treatment of coronary artery disease. The stent (Xience Prime, Abbott) is indicated for the improvement of coronary artery luminal diameter in patients with symptomatic ...
Abbott's XIENCE PRIME Stent Wins US
Abbott to Present New Data for Key Vascular Products at TCT 2011PR Newswire (press release)
FDA Approves Abbott's Xience Prime Coronary StentMedIndia
Medical News Today -Forbes
all 65 news articles »